Dabrafenib, a clinically approved BRAF inhibitor, halts cavernoma progression and reduces lesion burden in mouse models of cerebral cavernous malformations independently of BRAF inhibition.
Vascular Malformations Diagnosis and Treatment
Moving in bioRxiv and Science Translational Medicine.
- Moved, week to 23 Oct 2026
- 0
- Papers in 60 days
- 2
Add Vascular Malformations Diagnosis and Treatment as an interest in JClubFree on iPhone and Android · interests shape Home, Discover and your digest
Rebuilt
Moved this week
Nothing in this topic has moved yet this week.
Latest in Vascular Malformations Diagnosis and Treatment
Newest first · last 60 days
Add Vascular Malformations Diagnosis and Treatment as an interest in JClub
Browse JClub
Journals this month
- bioRxiv6192
- medRxiv1716
- PNAS472
- Sci Adv398
- JAMA274
- Environ Res230
- BMJ200
- Nat Commun171
- Environ Pollution165
- Nature161
- NEJM146
- Science141
- Lancet132
- Cell Rep130
- Curr Biol108
- J Exp Bot108
- mBio107
- Plant Cell Environ107
Topics moving, week to 23 Oct 2026
- Single-cell and spatial transcriptomics6
- Neuroinflammation and Neurodegeneration Mechanisms5
- Bacteriophages and microbial interactions5
- Gut microbiota and health5
- Genomics and Phylogenetic Studies4
- Cancer Genomics and Diagnostics4
- Cancer Immunotherapy and Biomarkers4
- Alzheimer's disease research and treatments3
- Inflammatory Bowel Disease3
- Influenza Virus Research Studies3